MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis

Aug 8, 2016Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

MicroRNA-328 as a Possible Target to Reduce Scarring in Heart Tissue

AI simplified

Abstract

miR-328 was significantly upregulated in the border zone of infarcted myocardium in mice.

  • Deregulated myocardial fibrosis is linked to various heart conditions and is considered a major cause of heart disease.
  • TGFβRIII was downregulated while TGF-β1 was upregulated in the context of increased cardiac fibrosis.
  • miR-328 may stimulate TGF-β1 signaling and promote collagen production in heart cells.
  • The pro-fibrotic effects of miR-328 are associated with its targeting of TGFβRIII.
  • Treatment with miR-328 antisense significantly reduced cardiac fibrosis in the infarcted heart.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free